Letermovir for CMV Prevention After Lung Transplantation

NCT05041426 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Lung Transplant
CMV

Interventions

DRUG: Letermovir
DRUG: Valganciclovir

Sponsor

Fernanda P Silveira, MD, MS

Collaborators

[object Object]